Unknown NA INTERVENTIONAL 1-arm NCT05772507

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

Assessment of the Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings in Local Management of Acute and Chronic Wounds at Risk of Local Infection or With Clinical Signs of Local Infection

Sponsor: Laboratoires URGO

Conditions Acute Wounds Diabetic Foot Ulcer Pressure Ulcer Venous Leg Ulcer Wound Infection

Interventions URGO AWC_008 dressing or URGO AWC_022 dressing

Updated 5 times since 2023 Last updated: Sep 25, 2023 Started: Aug 22, 2023 Primary completion: Jul 31, 2024 Completion: Oct 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Wounds and Diabetic Foot Ulcer and is currently ongoing. Laboratoires URGO leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Apr 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2023 — Oct 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laboratoires URGO

Data source: Laboratoires URGO

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dijon, France